Cisco Surges on Earnings Beat and AI Restructuring Plan
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy DOCS?
Source: seekingalpha
- Earnings Beat: Cisco Systems (CSCO) shares surged 20% following a strong FQ3 earnings report, with revenue guidance of $62.8B to $63B exceeding market expectations, indicating robust demand in the AI infrastructure sector.
- Restructuring Plan: The company announced a workforce reduction of approximately 4,000 employees, or 5% of its total staff, with expected restructuring charges of about $1B spread across fiscal years 2026 and 2027, aimed at reallocating resources towards high-speed networking and next-generation data centers.
- Positive Market Reaction: CEO Chuck Robbins emphasized that the restructuring focuses on talent repositioning rather than mere cost-cutting, with investor sentiment bolstered by an increased AI infrastructure order outlook rising from $5B to $9B, enhancing market confidence.
- Increased Competitive Pressure: Despite Cisco's strong performance, Doximity (DOCS) shares fell 21% due to disappointing earnings, highlighting concerns over advertising and pharmaceutical spending pressures on its healthcare platform, which raises worries about overall growth momentum.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DOCS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DOCS
Wall Street analysts forecast DOCS stock price to rise
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 19.580
Low
25.00
Averages
42.75
High
63.00
Current: 19.580
Low
25.00
Averages
42.75
High
63.00
About DOCS
Doximity, Inc. operates as a digital platform for United States medical professionals. The Company provides an online platform which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Its marketing solutions provide customers to share content on the network. Its hiring solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates. Its Workflow solutions allow customers to initiate voice and video calls with patients and manage on-call scheduling.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Bitcoin-Linked Stocks Rise as Starbucks Gets Upgrade
- Bitcoin-Linked Stocks Rise: Bitcoin rose 2% as the Senate Banking Committee discussed a regulatory framework for cryptocurrencies, with Coinbase shares jumping nearly 9%, indicating growing market confidence that could drive future growth for related companies.
- Starbucks Upgrade: TD Cowen upgraded Starbucks from hold to buy, raising its price target from $106 to $120, with analysts noting multiple positive sales drivers in a strong market backdrop, suggesting improved performance ahead.
- Ford Stock Surge: Ford shares rose 7%, adding to a 13% gain from Wednesday, as Morgan Stanley highlighted its energy storage business and partnership with CATL, projecting a $3 billion incremental revenue opportunity for Ford's Model e segment.
- Applied Materials Earnings Outlook: Applied Materials saw a 2% increase in shares ahead of its fiscal second-quarter results, with analysts expecting earnings of $2.66 per share and revenue of $7.68 billion, reflecting sustained optimism about semiconductor equipment demand.
See More
Doximity Shares Plunge 25% to Lowest Level Since IPO
- Disappointing Guidance: Doximity (DOCS) experienced a ~25% drop in stock price after its Q4 fiscal 2026 guidance failed to meet Wall Street expectations, reaching its lowest level since its 2021 IPO, indicating market concerns over future growth.
- Analyst Downgrade: KeyBanc Capital Markets downgraded Doximity from Overweight to Sector Weight, projecting fiscal 2027 revenue between $664 million and $676 million due to the AI Search product missing the sales peak, highlighting a lack of catalysts and increased downside risk.
- Market Share Challenges: Analyst Scott Schoenhaus noted that Doximity is not gaining market share this year as budget managers prefer cutting-edge AI or low-cost options over its premium offerings, reflecting a more competitive market landscape.
- AI Investment Year: While Doximity is catching up in AI, the anticipated revenue from the AI Search product is not expected until the second half of 2027, putting pressure on the company's growth outlook and indicating insufficient competitiveness in the digital advertising market.
See More
Doximity Shares Drop 24% After Disappointing Q4 Earnings Report
- Disappointing Performance: Doximity's Q4 sales rose by 5% and free cash flow (FCF) increased by 11%, yet the company fell short of Wall Street's earnings expectations, resulting in a 24% drop in share price as of Thursday morning.
- Conservative Future Outlook: Management's full-year revenue growth guidance for 2027 is only 3% to 5%, coupled with a declining adjusted EBITDA margin, indicating significant growth challenges ahead for the company.
- Increased AI Investment: Despite profitability pressures, Doximity is ramping up investments in AI products, which are expected to further impact margins; however, the company is making promising strides in technology adoption.
- Stable Market Position: With 85% of U.S. physicians on its network and partnerships with 20 of the top hospitals and pharmaceutical companies, Doximity's leadership remains intact, although the industry slowdown will still pose challenges.
See More
Key Market Highlights for Today
- Cerebras IPO: Cerebras Systems successfully raised $5.5 billion in its IPO today, focusing on ultra-fast AI chip processing, with OpenAI committing to purchase its computing capacity, indicating strong market demand for efficient AI computing.
- Cisco's Strong Quarter: Cisco reported a blowout quarter with robust data center performance, sending shares up nearly 15% in premarket trading, reflecting massive demand for networking equipment and underscoring the ongoing growth in AI spending, enhancing the investment case for data center stocks.
- Dell Price Target Increase: Citi raised Dell's price target from $235 to $290 ahead of its earnings report, anticipating continued strong performance in the server market; despite rising memory costs, Dell's scale and pricing agility are expected to provide competitive advantages.
- Broadcom Price Target Boost: Wells Fargo increased Broadcom's price target from $430 to $545, significantly raising AI chip revenue forecasts, highlighting the underappreciated potential in its networking segment, which could drive stock price appreciation.
See More
Cisco's Transformation in the AI Era
- Earnings Surge: Cisco (CSCO) saw a 20% pre-market jump, driven by a positive outlook from its business restructuring, with CFO Mark Patterson indicating an expansion of its silicon portfolio to meet data center demands, thereby enhancing its competitive edge in the AI market.
- Job Cuts and Investments: CEO Chuck Robbins announced nearly 4,000 job cuts; however, the company plans to increase investments in AI, aiming to shift resources towards areas with the strongest demand and long-term value creation, ensuring sustainable growth in the future.
- Chinese Market Opportunities: Alibaba (BABA) and JD.com (JD) received U.S. approval to purchase Nvidia's H200 chips, although no deliveries have been made yet, indicating a significant potential revenue opportunity for Nvidia in the Chinese market, which could impact its dominance in the global chip market.
- AI-Driven Growth: Cellebrite DI (CLBT) is expected to report an 18% year-over-year revenue growth, primarily driven by strong demand for AI-driven investigative tools, showcasing the company's robust execution and adaptability in the AI sector.
See More
Biogen Shares Rise 4% After Advancing Alzheimer's Drug to Phase 3 Trial
- Biogen Drug Advancement: Biogen announced that its experimental Alzheimer's drug will advance to a phase 3 trial despite not meeting the primary goal in phase 2, with cognitive benefits observed, leading to a 4% increase in stock price and boosting market confidence in its R&D capabilities.
- Versant Media Growth: Versant Media Group's shares surged 14.5% after reporting revenue growth in content licensing and digital platforms, even as overall revenue declined due to ongoing drops in pay TV networks and advertising, with adjusted EBITDA reaching $704 million, surpassing the $608 million expected by analysts, indicating success in its digital transformation.
- Yeti's Strong Performance: Yeti Holdings saw a 10% rise in stock price after reporting adjusted earnings of 26 cents per share in the first quarter, exceeding the 18 cents expected by analysts, while its revenue of $380.4 million also topped the $374.7 million consensus estimate, reflecting robust performance in the outdoor products market.
- Cisco's Strong Guidance: Cisco Systems shares jumped 15% following third-quarter results and guidance that exceeded Wall Street expectations, with adjusted earnings projected between $1.16 and $1.18 per share and revenue between $16.7 billion and $16.9 billion, showcasing strong growth potential in the software market.
See More
Bitcoin-Linked Stocks Rise as Starbucks Gets Upgrade
- Bitcoin-Linked Stocks Rise: Bitcoin rose 2% as the Senate Banking Committee discussed a regulatory framework for cryptocurrencies, with Coinbase shares jumping nearly 9%, indicating growing market confidence that could drive future growth for related companies.
- Starbucks Upgrade: TD Cowen upgraded Starbucks from hold to buy, raising its price target from $106 to $120, with analysts noting multiple positive sales drivers in a strong market backdrop, suggesting improved performance ahead.
- Ford Stock Surge: Ford shares rose 7%, adding to a 13% gain from Wednesday, as Morgan Stanley highlighted its energy storage business and partnership with CATL, projecting a $3 billion incremental revenue opportunity for Ford's Model e segment.
- Applied Materials Earnings Outlook: Applied Materials saw a 2% increase in shares ahead of its fiscal second-quarter results, with analysts expecting earnings of $2.66 per share and revenue of $7.68 billion, reflecting sustained optimism about semiconductor equipment demand.
See More
Doximity Shares Plunge 25% to Lowest Level Since IPO
- Disappointing Guidance: Doximity (DOCS) experienced a ~25% drop in stock price after its Q4 fiscal 2026 guidance failed to meet Wall Street expectations, reaching its lowest level since its 2021 IPO, indicating market concerns over future growth.
- Analyst Downgrade: KeyBanc Capital Markets downgraded Doximity from Overweight to Sector Weight, projecting fiscal 2027 revenue between $664 million and $676 million due to the AI Search product missing the sales peak, highlighting a lack of catalysts and increased downside risk.
- Market Share Challenges: Analyst Scott Schoenhaus noted that Doximity is not gaining market share this year as budget managers prefer cutting-edge AI or low-cost options over its premium offerings, reflecting a more competitive market landscape.
- AI Investment Year: While Doximity is catching up in AI, the anticipated revenue from the AI Search product is not expected until the second half of 2027, putting pressure on the company's growth outlook and indicating insufficient competitiveness in the digital advertising market.
See More
Doximity Shares Drop 24% After Disappointing Q4 Earnings Report
- Disappointing Performance: Doximity's Q4 sales rose by 5% and free cash flow (FCF) increased by 11%, yet the company fell short of Wall Street's earnings expectations, resulting in a 24% drop in share price as of Thursday morning.
- Conservative Future Outlook: Management's full-year revenue growth guidance for 2027 is only 3% to 5%, coupled with a declining adjusted EBITDA margin, indicating significant growth challenges ahead for the company.
- Increased AI Investment: Despite profitability pressures, Doximity is ramping up investments in AI products, which are expected to further impact margins; however, the company is making promising strides in technology adoption.
- Stable Market Position: With 85% of U.S. physicians on its network and partnerships with 20 of the top hospitals and pharmaceutical companies, Doximity's leadership remains intact, although the industry slowdown will still pose challenges.
See More
Key Market Highlights for Today
- Cerebras IPO: Cerebras Systems successfully raised $5.5 billion in its IPO today, focusing on ultra-fast AI chip processing, with OpenAI committing to purchase its computing capacity, indicating strong market demand for efficient AI computing.
- Cisco's Strong Quarter: Cisco reported a blowout quarter with robust data center performance, sending shares up nearly 15% in premarket trading, reflecting massive demand for networking equipment and underscoring the ongoing growth in AI spending, enhancing the investment case for data center stocks.
- Dell Price Target Increase: Citi raised Dell's price target from $235 to $290 ahead of its earnings report, anticipating continued strong performance in the server market; despite rising memory costs, Dell's scale and pricing agility are expected to provide competitive advantages.
- Broadcom Price Target Boost: Wells Fargo increased Broadcom's price target from $430 to $545, significantly raising AI chip revenue forecasts, highlighting the underappreciated potential in its networking segment, which could drive stock price appreciation.
See More
Cisco's Transformation in the AI Era
- Earnings Surge: Cisco (CSCO) saw a 20% pre-market jump, driven by a positive outlook from its business restructuring, with CFO Mark Patterson indicating an expansion of its silicon portfolio to meet data center demands, thereby enhancing its competitive edge in the AI market.
- Job Cuts and Investments: CEO Chuck Robbins announced nearly 4,000 job cuts; however, the company plans to increase investments in AI, aiming to shift resources towards areas with the strongest demand and long-term value creation, ensuring sustainable growth in the future.
- Chinese Market Opportunities: Alibaba (BABA) and JD.com (JD) received U.S. approval to purchase Nvidia's H200 chips, although no deliveries have been made yet, indicating a significant potential revenue opportunity for Nvidia in the Chinese market, which could impact its dominance in the global chip market.
- AI-Driven Growth: Cellebrite DI (CLBT) is expected to report an 18% year-over-year revenue growth, primarily driven by strong demand for AI-driven investigative tools, showcasing the company's robust execution and adaptability in the AI sector.
See More
Biogen Shares Rise 4% After Advancing Alzheimer's Drug to Phase 3 Trial
- Biogen Drug Advancement: Biogen announced that its experimental Alzheimer's drug will advance to a phase 3 trial despite not meeting the primary goal in phase 2, with cognitive benefits observed, leading to a 4% increase in stock price and boosting market confidence in its R&D capabilities.
- Versant Media Growth: Versant Media Group's shares surged 14.5% after reporting revenue growth in content licensing and digital platforms, even as overall revenue declined due to ongoing drops in pay TV networks and advertising, with adjusted EBITDA reaching $704 million, surpassing the $608 million expected by analysts, indicating success in its digital transformation.
- Yeti's Strong Performance: Yeti Holdings saw a 10% rise in stock price after reporting adjusted earnings of 26 cents per share in the first quarter, exceeding the 18 cents expected by analysts, while its revenue of $380.4 million also topped the $374.7 million consensus estimate, reflecting robust performance in the outdoor products market.
- Cisco's Strong Guidance: Cisco Systems shares jumped 15% following third-quarter results and guidance that exceeded Wall Street expectations, with adjusted earnings projected between $1.16 and $1.18 per share and revenue between $16.7 billion and $16.9 billion, showcasing strong growth potential in the software market.
See More
